OCTET does not demonstrate a lack of effectiveness for community treatment orders by Curtis, D
The Oxford Community Treatment Order Evaluation Trial,
known as OCTET and prominently reported in The Lancet,
found no difference in outcome between patients
randomised to be made subject to a community treatment
order (CTO) or to be managed with Section 17 leave and
discharge.1 The authors concluded: ‘In well coordinated
mental health services the imposition of compulsory
supervision does not reduce the rate of readmission of
psychotic patients’. An accompanying commentary2
declares that ‘the case for urgent review of this legislation,
both at government level and within the professions
involved in CTO use, is now strong’, although it does then
recommend sensible alternative methods to better assess
the effect of CTOs. In a subsequent issue of The Lancet,
correspondence was published drawing attention to some,
but not all, of the problems of the study, but this will not
have achieved the same prominence as the original
article.3-7
In fact, the results of OCTET by no means support the
authors’ conclusions and indeed the study design itself
meant that the hypothesis of effectiveness of CTOs, or a lack
of it, could not be properly tested. Within the report the
authors do express some of the relevant caveats and
recognise problems with the design and execution of the
study. However, they then make bold statements which are
not borne out by an objective consideration of the results
and which are potentially damaging to patient care, both
nationally and internationally. The use of compulsory
treatment in the community is controversial and it would
be unfortunate if the ﬁndings of this study were
misinterpreted as to cast doubt on its effectiveness.
There are a number of reasons why OCTET cannot
throw light on the effectiveness of CTOs and these reasons
are to some extent related to each other. Broadly, the
concerns relate to the patients included, the clinicians who
participated and the mode of implementation of the CTOs.
Finally, there are concerns about the general attitudes of the
researchers, and possibly of the participating clinicians as
well, to the use of compulsory treatment.
Attitudes to compulsory treatment
The researchers rightly note that there is wide variation of
practice regarding the use of CTOs and, more widely, of the
powers provided by the Mental Health Act 1983. However,
in several places the wording used raises questions about
the researchers’ own attitudes. To take one example, they
say that participants were randomised ‘to be discharged
from hospital either on CTO or Section 17 leave’. But a
patient who has been granted Section 17 leave has not been
discharged. He has been allowed home on a temporary basis
and remains subject to recall for further hospital treatment.
Elsewhere they write of using Section 17 ‘for some hours or
days, or even exceptionally weeks’ and that it is ‘a well
established rehabilitation practice, used for brief periods’.
Most strikingly, they write, ‘Patients can be discharged
directly from Section 3 without the need for either Section
17 leave or a CTO, and most are.’
The ﬁnal claim seems to be plainly incorrect. It would
be practically unheard of for a patient to be discharged
directly from detention under Section 3 without any use of
Section 17 leave and it is certainly not the case that ‘most
are’. The other statements give the impression that the
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researchers’ view of Section 17 leave is that it might be used
brieﬂy following a period of detention as a form of trial of
discharge arrangements before proceeding, all being well, to
actual discharge. It is true that some psychiatrists do only
use Section 17 leave brieﬂy in this way but there are others
who implemented a quite different approach, at least before
CTOs became available. This approach would have been to
allow the patient home on ‘extended leave’ for months at a
time, with acceptance of treatment as a condition of
continuing leave. Indeed, some psychiatrists would
intermittently recall such patients to hospital for the
purpose of having their period of detention under
Section 3 extended (as the renewal could only be
carried out while the patient was in hospital), resulting in de
facto compulsory community treatment. This practice was
eventually deemed to be unlawful but nevertheless some
psychiatrists would continue to manage patients in the
community on Section 17 leave for periods of several
months until the Section 3 expired. For some patients such
an arrangement could continue for up to a year. If during
the period of leave there were problems necessitating recall
to hospital, then, if the section were close to expiring, the
psychiatrist could take the opportunity to renew the section
prior to a further period of leave.
Such a use of extended Section 17 leave is not without
its critics. However, it is undeniable that some psychiatrists
have been happy to use it in this way and they would argue
that it has enabled their patients to remain fairly well
outside of hospital for long periods of time. The point is that
the authors of the paper, who say that it might be used
‘exceptionally’ for ‘weeks’, seem clearly not to share this
outlook and actually fail even to acknowledge that such
practices exist. This observation means that there are
grounds for concern about the attitudes of at least some
of the authors. One also wonders whether those
psychiatrists who agreed to participate in the project had
similar views and might have had a general distaste for
assertively using the legal powers to enforce psychiatric
treatment. That is, one might suspect that psychiatrists who
strongly believed in the value of CTOs might have been
reluctant to submit their patients for randomisation.
Selection of patients
Although the randomisation is described as being between
the use of CTO and Section 17 leave, it is clear that what is
really meant is the use of CTO v. fairly brief Section 17 leave
followed by discharge. (We can infer that only a brief use of
Section 17 leave was intended both from the general outlook
communicated by the study authors and from the fact that
in practice patients were discharged after a median of only
8 days on leave.) Thus the only patients who might be
considered suitable for randomisation would be those for
whom discharge or CTO were thought to be equally suitable,
and hence would not include patients for whom the
provisions of a CTO were judged to be necessary. Even if
one does not accept the point that the period of Section 17
leave was expected to be brief, it remains the case that the
legal constraints would mean that it could not be continued
for longer than a matter of months, and hence any patient
expected to have a continuing requirement for compulsory
treatment in the community could not have been
considered eligible for randomisation.
Hence, it broadly seems that the only patients likely to
be entered for OCTET randomisation were those for whom
it is thought that the CTO would be unnecessary.
To emphasise this point, consider a patient who accepts
depot medication while subject to Section 3 and on
Section 17 leave, but who repeatedly refuses it and defaults
from follow-up as soon as any period of compulsion under
Section 3 ends. If such a pattern were established and if the
patient presented with signiﬁcant risk issues when unwell,
then they would represent a perfect candidate for the use of
a CTO, but they could not possibly have been selected for
randomisation and included in this study.
This issue is somewhat muddied by the authors’ report
that they obtained a legal opinion that there was an area of
equipoise between Section 17 and CTO regimes. This does
indeed seem reasonable if one considers the situation at a
single point in time. However, arguably the key difference
between the two is the length of time which they can be
applied for. For any patient who might need compulsory
treatment for more than a few months the two regimes
would obviously be substantially different and such a
patient could not have been included in the randomisation
process.
In general, it seems that the only patients who might
have been eligible for inclusion in the study were those for
whom one could make the judgement that a CTO was
unlikely to be particularly useful.
Selection of psychiatrists
As the authors point out, there is widespread variation in
attitudes of psychiatrists towards compulsory treatment. At
one extreme are psychiatrists who are reluctant to deprive
patients of autonomy and who will use compulsory
measures as sparingly as possible, even if they recognise
that this may lead to more distress or poorer functioning for
the patient, at least in the short term. At the other end are
psychiatrists who will take a more paternalistic approach
and who will enthusiastically use the powers provided by
the Mental Health Act to impose on patients’ treatment
plans which they regard as being in the best interests of the
patient and the wider public, even if the patient might be
vigorously opposed to them, at least in the short term.
Where CTOs are concerned, it is natural to assume that
some psychiatrists would regard them as providing a
long-awaited opportunity to ensure that patients would
continue to receive treatment in the community while
others would regard them as an unacceptable intrusion and
as a violation of their patients’ human rights. A spectrum in
between would consist of psychiatrists with a range of
different attitudes and expectations.
Arguably, the nature of the study meant that the
psychiatrists who volunteered to participate would be
largely those who were doubtful of the value of CTOs and
hence would be happy to submit patients for randomisation,
with the risk that they would end up being subject to
Section 17 for only a limited period of time. It would be
reasonable to assume that such psychiatrists would also
tend to be more reluctant to intervene assertively if a
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patient who had been placed on a CTO were to show early
signs of deterioration and/or non-compliance.
Thus, the study design might be expected to recruit
psychiatrists who were ambivalent about the usefulness of
CTOs as well as patients for whom the usefulness of a CTO
was deemed to be unclear.
However, there is an additional dimension regarding
the psychiatrists involved which is worthy of separate
consideration. This is that in at least some cases the
psychiatrist instituting the CTO would not be the same as
the one responsible for implementing it. The authors report
that almost all of the collaborating services underwent
reorganisation, sometimes resulting in the separation of in-
patient and out-patient services, and that many patients
were passed to psychiatrists unfamiliar with the trial. The
authors report a large number of protocol violations, where
the patient was not in fact provided with the intervention to
which they had been randomised, and they attribute these
in part to such changes in psychiatrist. They report that a
sensitivity analysis omitting protocol violations did not
alter the ﬁndings. Nevertheless, setting the protocol
violations aside, it seems clear that for many patients the
psychiatrist agreeing to randomisation was not the same as
the psychiatrist implementing the CTO. It is not difﬁcult to
imagine that a community psychiatrist, perhaps unfamiliar
with CTOs and perhaps unenthusiastic about them, might
not represent an ideal candidate to test their usefulness. Of
course, there is a widely held view that the split between
in-patient and out-patient psychiatry is of itself a powerful
contributor to the difﬁculties of maintaining patients in the
community. The so-called ‘functional split’ means that the
community psychiatrist is working with a patient who has
been acutely unwell in hospital and who has been made
subject to a treatment plan which somebody else has
instituted. A perverse incentive exists, which is that if the
patient gets admitted again then the community
psychiatrist will no longer have to look after them and
will no longer be responsible for any adverse events which
might befall the patient or those in contact with the patient.
It is not unreasonable to suspect that such considerations
could have had an impact on the degree to which the
responsible psychiatrist in the community made full use of
the available provisions of CTOs to do everything possible
to prevent the need for readmission.
OCTET in practice
I have argued that there could be a priori grounds to suspect
that OCTET might not have constituted a fair test of the
effectiveness of CTOs. The study might have tended to
incorporate psychiatrists who were dubious about their
value and who would have selected only patients who could
be managed equally well with or without a CTO. Such
patients might then have been looked after in the
community by other psychiatrists who might be even less
enthusiastic about CTOs in general and who might in fact
have had little interest in putting in the necessary effort to
see that the maximum value was gained from their use. Is
there any evidence to support this view? I believe that
there is.
First, I would draw attention to the extremely short
time for which Section 17 leave was used. The number of
days for which patients were subject to Section 17 leave is
stated as a median 8 and an interquartile range (IQR)
of 0-37, with a mean of 45.5 and a standard deviation of
80.7. So half of all patients randomised to the Section 17 arm
were fully discharged after just over a week on leave. And a
quarter never had any leave at all (though, admittedly, a few
of these may be patients who were randomised but then
never left hospital). Many psychiatrists would ﬁnd it very
difﬁcult to understand that there could be a patient who
could be included in the study because their clinical
condition was such that a CTO was ‘necessary’ while,
having been randomised to the Section 17 arm, after the
very briefest trial of leave or after no leave at all they could
be completely discharged.
The fact that the mean is so much higher than the
median implies that there were a handful of patients who
were kept on Section 17 leave for a long period of time.
However, the fact that the top of the IQR is stated to be 37
means that three-quarters of patients were discharged after
little more than a month of trial leave. Again, it is hard to
see that these are the patients which many psychiatrists
would envisage as being appropriately managed with a CTO.
Second, we can look at the length of time for which the
CTO itself was used in patients who were randomised to this
management plan. Here, the median number of days is given
as 183 with the mean being roughly the same, 170.1. The IQR
is given as 0-299. The ﬁrst thing to say is that it is difﬁcult
to believe that these ﬁgures are actually correct. The IQR
starting at zero would imply that a quarter of patients spent
no time at all subject to any legal constraint in the
community. This could either be because they were never
in fact discharged or because they were discharged but (as a
protocol violation) without any use being made of either a
CTO or Section 17 leave. It does seem somewhat unlikely
that such a high proportion of patients would have been
dealt with in this way, but if these ﬁgures are accurate then
they do emphasise how few patients were in reality
managed in accordance with the randomised allocation.
The mean and median periods for which patients in the
CTO arm were subjected to compulsory community
treatment were about 6 months. Section 17 leave can run
for variable amounts of time but a CTO would typically be
applied for distinct periods of 6 months at a time. Shorter
periods might be brought about by discharges directed by
tribunals, by readmission or by protocol violations involving
the use of Section 17 leave instead. The authors state: ‘The
median duration of the initial CTOs in our trial was 6
months, indicating that about half were being renewed’.
This seems to represent a fundamental misunderstanding of
the interpretation of a sample median. Given that many
participants will have had an identical value for the quantity
under consideration, here the number of days on compul-
sory community treatment, it is not the case that half of
participants will have had a value higher than this. In this
context, all the median tells us is that this was the middle
rank. We know that it cannot be the case that half of the
patients were subject to a CTO for 6 months and half for 12
months, because if so, the mean period would be 9 months,
whereas in reality it was slightly under 6. The higher value
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of the IQR of 299 implies that only a quarter of participants
were subject to a CTO for longer than 10 months. The fact
that the median period was 183 does not imply that half of
patients were subjected to a CTO for longer than 183 days,
but that a substantial number of participants were detained
for exactly 183 days, i.e. 6 months. Speaking approximately,
the summary statistics reported would be correct if a
quarter of patients were never in fact subject to a CTO, half
were subject to one period of 6 months and a quarter had
the CTO extended for a second period, meaning that it
continued for the 12-month follow-up period of the study.
This quarter-half-quarter pattern would much better ﬁt
with the results reported and would in fact mean that only a
third, not half, of patients who were originally placed on a
CTO then had it extended.
Having claimed that half of CTOs were renewed, the
authors then say that this is an indicator that they were
used appropriately. Regardless of whether the true propor-
tion was a third or a half, I believe that many psychiatrists
would strongly disagree with the judgement that this
represented appropriate usage. There is a view that the
true value of a CTO is to encourage a patient’s compliance
with a treatment plan over an extended period of time.
From such a perspective, the use of a CTO for ‘only’
6 months would not be appropriate. If one only wanted to
ensure compliance for a few months then logically one
could simply use the provisions of Section 17 leave. Thus
these ﬁgures provide another strong pointer to the
conclusion that the patients randomised in this study
were not those for whom a CTO might be expected to
offer beneﬁt.
Conclusions
There are grounds to suspect that OCTET was based on a
group of patients for whom there was no real indication for
the use of a CTO, and that they might have been managed by
psychiatrists who had little enthusiasm to utilise the
provisions of a CTO assertively over an extended period of
time to do everything possible to support patients to remain
in the community. It is undeniable that a very important
group of patients were completely excluded from the study
- those for whom discharge could not even be contemplated
if a CTO were not available as a management option.
It is a matter of some concern that the authors of the
study in fact acknowledge at least some of these
reservations but then draw conclusions which are
unjustiﬁed. They themselves allude to the clinicians and
patients who were not part of the study because arguments
in favour of the use of CTOs were so strong that
randomisation was precluded. But then they write: ‘The
evidence is now strong that the use of CTOs does not confer
early patient beneﬁts despite substantial curtailment of
individual freedoms’. Additionally, they write in the
abstract: ‘In well coordinated mental health services the
imposition of compulsory supervision does not reduce the
rate of readmission of psychotic patients’.
I believe that neither conclusion is justiﬁed by the
ﬁndings of this study. I believe that a more appropriate
conclusion would be that it remains a strong possibility that
a small subgroup of patients, characterised by repeated
relapses secondary to non-compliance and with only partial
insight, might derive enormous beneﬁt from more
prolonged periods of compulsory treatment in the
community and might be supported in building full and
productive lives outside hospital.
Whether or not CTOs are effective could not have been
determined by OCTET as it was designed. The effectiveness
of legislation and policy are difﬁcult or impossible to
evaluate using the kind of randomised clinical trial which
may be appropriate for individual components of treatment,
such as antipsychotic medication. I am not aware of any
clinical trial which has demonstrated that detention and
treatment under Section 3 of the Mental Health Act is
effective, and if one were to attempt such a trial one could
envisage that it would likewise produce negative results,
because the patients for whom it would be most useful
would be excluded from randomisation. The accompanying
commentary suggests that evidence might instead be sought
through the large-scale collation and analysis of routine
data,2 and this does indeed seem a more promising
approach. In any event, the ﬁndings from OCTET should
not be interpreted as telling us anything conclusive about
the effectiveness or otherwise of compulsory treatment in
the community.
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